Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this phase III study is to determine the safety and efficacy of difluprednate in the management of inflammation following ocular surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sirion Therapeutics, Inc.
• Treatments: Difluprednate; Fluprednisolone

Criteria

Inclusion Criteria:

• Scheduled for unilateral ocular surgery.

Exclusion Criteria:

• Systemic administration of any corticosteroid or immunosuppressive drug in the 2 weeks prior to study enrollment.